NCT03905408View on ClinicalTrials.gov

Pleurodesis Using Hypertonic Glucose to Treat Post-operative Air Leaks

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 17, 2019

Primary Completion Date

February 1, 2021

Study Completion Date

February 1, 2021

Conditions
Postoperative Air Leak
Interventions
DRUG

50 mL of 50% Glucose

1st dose

DRUG

100 mL of 50% Glucose

2nd dose

DRUG

150 mL of 50% Glucose

3rd dose

DRUG

200 mL of 50% Glucose

4th dose

Trial Locations (1)

N6A 5W9

London Health Sciences Centre, London

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT03905408 - Pleurodesis Using Hypertonic Glucose to Treat Post-operative Air Leaks | Biotech Hunter | Biotech Hunter